This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

ACT LEVETIRACETAM (2015-11-16)

Starting date:
November 16, 2015
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-55910

Affected Products

ACT LEVETIRACETAM

Reason

This lot may contain foreign tablets (ACT LEVETIRACETAM 250 mg tablets).

Depth of distribution

Wholesalers and retailers across Canada

Affected products

ACT LEVETIRACETAM

DIN, NPN, DIN-HIM
DIN 02274191
Dosage form

Film-coated tablets

Strength

Levetiracetam 500 mg

Lot or serial number

K40683

Companies
Recalling Firm
Actavis Pharma Company
6733 Mississauga Road, Unit 400
Mississauga
L5N 6J5
Ontario
CANADA
Marketing Authorization Holder
Actavis Pharma Company
6733 Mississauga Road, Unit 400
Mississauga
L5N 6J5
Ontario
CANADA

Date modified: